Role of Suppression of Endometriosis With Progestins Before IVF-ET

NACompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

April 30, 2020

Conditions
IVFEndometriosisPregnancy RateProgestinsGnRH-analogue
Interventions
DRUG

Dienogest

Group B (n=67) who had daily oral Dienogest 2 mg/d for 3 months before starting standard long protocol for IVF

DRUG

leuprorelin acetate

Group A (n=67) who had monthly depot GnRHa for 3 months before ovarian stimulation in IVF treatment (Ultra-long protocol)

Trial Locations (1)

Unknown

Minia Infertility research unit, Minya

All Listed Sponsors
lead

National Research Centre, Egypt

OTHER

NCT04500743 - Role of Suppression of Endometriosis With Progestins Before IVF-ET | Biotech Hunter | Biotech Hunter